Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Income Statement

Financials in millions EUR. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Operating Revenue	3.04	6.85	9.86	18.51	1.75	8.49
Other Revenue	-	-	-	-	0.28	0.18
Revenue	3.04	6.85	9.86	18.51	2.03	8.67
Revenue Growth (YoY)	-64.15%	-30.53%	-46.75%	810.30%	-76.53%	15.63%
Cost of Revenue	0.47	1.78	3.25	4.68	4.71	5.6
Gross Profit	2.57	5.07	6.61	13.83	-2.68	3.07
Selling, General & Admin	8.72	8.46	6.22	5.99	4.48	3.97
Research & Development	27.24	21.84	28.07	26.38	18.75	18.28
Other Operating Expenses	-2.42	-3.4	-0.14	-0.24	-0.07	-0.11
Operating Expenses	33.54	26.9	34.15	32.13	23.16	22.15
Operating Income	-30.97	-21.83	-27.55	-18.29	-25.84	-19.09
Interest Expense	-0	-0.14	-0.76	-0.84	-0.49	-0.01
Interest & Investment Income	1.02	1.42	7.55	0.24	-	-
Earnings From Equity Investments	-	-	-	-	-0.01	-0.07
Currency Exchange Gain (Loss)	-0.18	-0.18	-0.46	0.96	0	0.02
Other Non Operating Income (Expenses)	2.74	0.12	0.21	0.06	0.09	0.14
EBT Excluding Unusual Items	-27.4	-20.6	-21.01	-17.87	-26.26	-19.01
Gain (Loss) on Sale of Assets	0	0	0.03	0.02	-	0.01
Asset Writedown	-	-	-	-	-	-0
Other Unusual Items	1.22	1.22	0.63	0.07	0.12	0.63
Pretax Income	-26.18	-19.38	-20.35	-17.79	-26.14	-18.37
Income Tax Expense	-	-	-	1.92	-	-
Net Income	-26.18	-19.38	-20.35	-19.7	-26.14	-18.37
Net Income to Common	-26.18	-19.38	-20.35	-19.7	-26.14	-18.37
Shares Outstanding (Basic)	47	47	47	37	33	30
Shares Outstanding (Diluted)	47	47	47	37	33	30
Shares Change (YoY)	2.26%	0.02%	25.14%	14.56%	8.72%	5.98%
EPS (Basic)	-0.55	-0.42	-0.44	-0.53	-0.80	-0.61
EPS (Diluted)	-0.55	-0.42	-0.44	-0.53	-0.80	-0.61
Free Cash Flow	-32	-30.04	-34.61	-9.45	-27.85	-19.26
Free Cash Flow Per Share	-0.68	-0.65	-0.74	-0.25	-0.86	-0.64
Gross Margin	84.66%	74.00%	67.01%	74.72%	-131.69%	35.39%
Operating Margin	-1019.65%	-318.71%	-279.41%	-98.81%	-1270.65%	-220.22%
Profit Margin	-861.83%	-282.98%	-206.38%	-106.42%	-1285.20%	-211.95%
Free Cash Flow Margin	-1053.39%	-438.64%	-351.07%	-51.03%	-1369.57%	-222.24%
EBITDA	-30.24	-21.1	-26.84	-17.7	-25.2	-18.46
EBITDA Margin	-	-	-272.20%	-95.63%	-	-212.99%
D&A For EBITDA	0.73	0.73	0.71	0.59	0.64	0.63
EBIT	-30.97	-21.83	-27.55	-18.29	-25.84	-19.09
EBIT Margin	-	-	-279.41%	-98.81%	-	-220.22%
Revenue as Reported	10.77	11.96	16.8	19.86	2.31	9.58

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.